CD274 and neoplasm: Due to the defective activity of their HR DNA repair machinery, BRCA1/2-mutated HGSOCs exhibit a higher tumor mutational burden, thus expressing more tumor-specific neoantigens and harboring increased amounts of TILs and PD-1/PD-L1 [23].